This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Olumiant
  • /
  • A Study of Baricitinib in Participants With System...
Clinical trial

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (BRAVE II)

Read time: 1 mins
Last updated:18th Oct 2020
Status: Active, not recruiting
Identifier: NCT03616964
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest